 Litigation arising from these agreements is still pending including an FTC suit filed in April 2008.Apotex received regulatory approval in Canada despite a suit from Cephalon's marketing partner in Canada, Shire Pharmaceuticals.Cephalon has sued Apotex in the US to prevent it from releasing a genericized armodafinil (Nuvigil).